BACH BOLIGCENTER ApS: Financial statements 2015
CVR: 12024584
Source: annual report 2015, Danish Business Authority
01/05/2014 – 30/04/2015
BACH BOLIGCENTER ApS (CVR 12024584) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -13,748 and a net result of DKK 233,732 compared with DKK 20,771 the year before. Equity in the 2015 report amounted to DKK 1,780,344. The solvency ratio was 96.5%.
- Gross Profit
- DKK -13,748
- Profit/Loss
- DKK 233,732
- Equity
- DKK 1,780,344
- Total Assets
- DKK 1,844,016
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -14K | 234K | 1.8M | - |
| 2014 | - | -13K | 21K | 1.6M | - |
| 2013 | - | -12K | 89K | 1.6M | - |
Official annual report
How creditworthy is BACH BOLIGCENTER ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of September 1, 2015, Kvist & Jensen Statsautoriseret Revisionspartnerselskab has been appointed auditor of BACH BOLIGCENTER ApS.
As of September 1, 2015, REVISIONSFIRMAET KVIST OG JENSEN A/S has stepped down as auditor of BACH BOLIGCENTER ApS.
About BACH BOLIGCENTER ApS
BACH BOLIGCENTER ApS is a Danish company of the type Anpartsselskab based in Hammel, founded in 1988. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named EMBRYODAN ApS. The management consists of Geo Koch. The company is owned by Geo Koch. The company has 1 employee (2023). In 2026, the company reported a gross profit of DKK -12,635 and a net result of DKK 3,958 compared with DKK -35,885 the year before. Equity in the 2026 report amounted to DKK 243,122.